Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-018768
Filing Date
2021-05-07
Accepted
2021-05-07 20:45:37
Documents
2
Period of Report
2021-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3927
2 EX-24 DOCUMENT attachment1.htm EX-24 4026
  Complete submission text file 0000899243-21-018768.txt   9373
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Issuer) CIK: 0001403752 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 860 WASHINGTON STREET 10TH FLOOR NEW YORK NY 10014
Business Address
Neu Kelvin (Reporting) CIK: 0001554699 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38068 | Film No.: 21904898